These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4907101)

  • 1. Is a double-blind clinical trial really double-blind? A report of doctors' medication guesses.
    Rickels K; Lipman RS; Fisher S; Park LC; Uhlenhuth EH
    Psychopharmacologia; 1970; 16(4):329-36. PubMed ID: 4907101
    [No Abstract]   [Full Text] [Related]  

  • 2. Two double-blind, controlled studies comparing chlorethate, a new sedative-tranquilizer, with meprobamate and with phenobarbital.
    Beard WJ; Free SM
    J Clin Pharmacol J New Drugs; 1967; 7(1):41-5. PubMed ID: 4951239
    [No Abstract]   [Full Text] [Related]  

  • 3. Side reactions on meprobamate and placebo.
    Rickels K; Snow L; Uhlenhuth EH; Lipman RS; Park LC; Fisher S
    Dis Nerv Syst; 1967 Jan; 28(1):39-45. PubMed ID: 5334842
    [No Abstract]   [Full Text] [Related]  

  • 4. Medication, anxiety reduction and patient report of significant life situation events.
    Lipman RS; Covi L; Derogatis LR; Rickels K; Uhlenhuth EH
    Dis Nerv Syst; 1971 Apr; 32(4):240-4. PubMed ID: 4932964
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blind evaluation of an analgesic-tranquilizer combination for treating musculoskeletal pain associated with anxiety.
    Winkelman NW; Richards DJ
    Curr Ther Res Clin Exp; 1975 Apr; 17(4):352-60. PubMed ID: 804382
    [No Abstract]   [Full Text] [Related]  

  • 6. Predicting the relief of anxiety with meprobamate. An attempt at replication.
    Uhlenhuth EH; Covi L; Rickels K; Lipman RS; Park LC
    Arch Gen Psychiatry; 1972 Jan; 26(1):85-91. PubMed ID: 4550552
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug treatment in depression. Antidepressant or tranquilizer?
    Rickels K; Raab E; DeSilverio R; Etemad B
    JAMA; 1967 Aug; 201(9):675-81. PubMed ID: 5340332
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy.
    Uhlenhuth EH; Rickels K; Fisher S; Park LC; Lipman RS; Mock J
    Psychopharmacologia; 1966; 9(5):392-418. PubMed ID: 4872909
    [No Abstract]   [Full Text] [Related]  

  • 9. Meprobamate and benactyzine (Deprol) in the treatment of depression in general practice. (A controlled study).
    Gordon PE
    Dis Nerv Syst; 1967 Apr; 28(4):234-40. PubMed ID: 5337279
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug effects and initial severity of symptomatology.
    Fisher S; Lipman RS; Uhlenhuth EH; Rickels K; Park LC
    Psychopharmacologia; 1965 Jan; 7(1):57-60. PubMed ID: 5318924
    [No Abstract]   [Full Text] [Related]  

  • 11. Patient personality and demographic factors as predictors of early response to psychotropic drug treatment.
    Downing RW; Rickels K
    Compr Psychiatry; 1970 Nov; 11(6):568-75. PubMed ID: 4923050
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers.
    Rickels K; Lipman RS; Park LC; Covi L; Uhlenhugh EH; Mock JE
    Psychopharmacologia; 1971; 20(2):128-52. PubMed ID: 4933093
    [No Abstract]   [Full Text] [Related]  

  • 13. An apparent algesic effect of meprobamate.
    Kantor TG; Laska E; Streem A
    J Clin Pharmacol New Drugs; 1973 Apr; 13(4):152-9. PubMed ID: 4570992
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlled psychoparmacological research in private psychiatric practice.
    Rickels K; Cattell RB; Weise C; Gray B; Yee R; Mallin A; Aaronson HG
    Psychopharmacologia; 1966; 9(4):288-306. PubMed ID: 4871472
    [No Abstract]   [Full Text] [Related]  

  • 15. Relief of musculoskeletal and associated psychopathological symptoms with meprobamate and aspirin: a controlled study.
    Gilbert MM; Koepke HH
    Curr Ther Res Clin Exp; 1973 Nov; 15(11):820-32. PubMed ID: 4201595
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicting the relief of anxiety with meprobamate. Nondrug factors in the response of psychoneurotic outpatients.
    Uhlenhuth EH; Lipman RS; Rickels K; Fisher S; Covi L; Park LC
    Arch Gen Psychiatry; 1968 Nov; 19(5):619-30. PubMed ID: 5680975
    [No Abstract]   [Full Text] [Related]  

  • 17. The symptomatic relief of anxiety with meprobamate, phenobarbital and placebo.
    UHLENHUTH EH; CANTER A; NEUSTADT JO; PAYSON HE
    Am J Psychiatry; 1959 Apr; 115(10):905-10. PubMed ID: 13637255
    [No Abstract]   [Full Text] [Related]  

  • 18. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of a kymograph in a comparative trial of flunitrazepam and meprobamate in elderly patients.
    Brocklehurst JC; Carty MH; Skorecki J
    Curr Med Res Opin; 1978; 5(8):663-8. PubMed ID: 30598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug response and important external events in the patient's life.
    Rickels K; Cattell R; MacAfee A; Hesbacher P
    Dis Nerv Syst; 1965 Dec; 26(12):782-6. PubMed ID: 5321915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.